In Grade 3 tumors (Figure 2Ad), CLDN8 expression was significantly reduced, exhibiting a homogeneous staining pattern with minimal membrane localization, further indicating the loss of barrier function in high-grade breast cancer. This evidence concerns the gene CLDN8 and breast cancer.